Arjan J. Van Adrichem
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Toward universal protein post-translational modification detection in high throughput format.
Journal: Chemical communications (Cambridge, England)
Published: March 03, 2018
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.
Journal: Cell chemical biology
Published: August 22, 2017
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.
Journal: Oncotarget
Published: December 21, 2016
Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia.
Journal: Leukemia
Published: October 01, 2015
MgcRacGAP inhibition stimulates JAK-dependent STAT3 activity.
Journal: FEBS letters
Published: August 12, 2015
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.
Journal: Blood
Published: October 29, 2014
Discovery of MINC1, a GTPase-activating protein small molecule inhibitor, targeting MgcRacGAP.
Journal: Combinatorial chemistry & high throughput screening
Published: June 27, 2014
A homogeneous quenching resonance energy transfer assay for the kinetic analysis of the GTPase nucleotide exchange reaction.
Journal: Analytical and bioanalytical chemistry
Published: January 23, 2014
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.
Journal: Blood
Published: April 19, 2013
Somatic STAT3 mutations in large granular lymphocytic leukemia.
Journal: The New England journal of medicine
Published: May 18, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026